Laurus Labs share news, announcements and annual reports
NSE: LAURUSLABSBSE: 540222Pharmaceuticals & BiotechnologyMid Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹2,244.00.
30 Oct: open ₹2,246.60, high ₹2,405.50, low ₹2,206.10
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,29,972 Cr171st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 97.00
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 21.45
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.08%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 24.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 21.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.40
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 79,13,29731.3% delivered
Laurus Labs analyst meets
131 filed, newest first. Page 2 of 3.
Oct 2022
13 Oct · Analysts
Sep 2022
17 Sep · Analysts
12 Sep · Analysts
Aug 2022
22 Aug · Analysts
Jul 2022
21 Jul · Analysts
Jun 2022
20 Jun · Analysts
13 Jun · Analysts
Apr 2022
25 Apr · Analysts
Mar 2022
14 Mar · Analysts
11 Mar · Analysts
Feb 2022
22 Feb · Analysts
22 Feb · Analysts
21 Feb · Analysts
7 Feb · Analysts
Jan 2022
21 Jan · Analysts
Oct 2021
21 Oct · Analysts
Sep 2021
17 Sep · Analysts
13 Sep · Analysts
Aug 2021
25 Aug · Analysts
3 Aug · Analysts
Jul 2021
26 Jul · Analysts
May 2021
18 May · Analysts
5 May · Analysts
Apr 2021
26 Apr · Analysts
Feb 2021
17 Feb · Analysts
5 Feb · Analysts
2 Feb · Analysts
Jan 2021
25 Jan · Analysts
Dec 2020
16 Dec · Analysts
8 Dec · Analysts
2 Dec · Analysts
2 Dec · Analysts
Nov 2020
25 Nov · Analysts
25 Nov · Analysts
23 Nov · Analysts
23 Nov · Analysts
18 Nov · Analysts
9 Nov · Analysts
Oct 2020
26 Oct · Analysts
26 Oct · Analysts
Sep 2020
28 Sep · Analysts
2 Sep · Analysts
Aug 2020
18 Aug · Analysts
5 Aug · Analysts
Jul 2020
27 Jul · Analysts
May 2020
9 May · Analysts
Apr 2020
27 Apr · Analysts
Feb 2020
21 Feb · Analysts
10 Feb · Analysts
Jan 2020
27 Jan · Analysts